In vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosis.
The aim of the present study was to evaluate the effect of the combination of rifampicin (RIF) and verapamil (VP) against the Mycobacterium tuberculosis H37Rv reference strain and six multidrug-resistant (MDR) M. tuberculosis clinical isolates by determining Time-Kill Curves and the ability to efflu...
Main Authors: | Fernanda de Oliveira Demitto, Renata Claro Ribeiro do Amaral, Flaviane Granero Maltempe, Vera Lúcia Dias Siqueira, Regiane Bertin de Lima Scodro, Mariana Aparecida Lopes, Katiany R Caleffi-Ferracioli, Pedro Henrique Canezin, Rosilene Fressatti Cardoso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4331551?pdf=render |
Similar Items
-
Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis.
by: Fernanda de Oliveira Demitto, et al.
Published: (2015-01-01) -
Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?
by: Renata Claro Ribeiro do Amaral, et al.
Published: (2020-11-01) -
Fast detection of Mycobacterium tuberculosis in culture-positive sputum samples by nitrate reductase activity
by: Jean Eduardo Meneguello, et al.
Published: (2018-05-01) -
Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR
by: Katiany Rizzieri Caleffi-Ferracioli, et al.
Published: (2018-11-01) -
COMORBIDADES E ÓBITOS POR COVID-19 NO BRASIL
by: Izabella Ventura de Souza, et al.
Published: (2021-12-01)